- News
News
University of Glasgow spinout secures £8.75m for tennis elbow treatment trials
Causeway Therapeutics, a University of Glasgow spin-out specializing in tendon disease has raised £8.75M from investors to to advance development of microRNA therapeutics.
More
- News
News
UWS research suggests grass species offers cancer treatment potential
A drought-resistant perennial grass could help in the fight against cancer, University of the West of Scotland (UWS) research has revealed.
More
- News
News
Strathclyde launch online course to support medicine use for older people with sensory impairments
The course is aimed at people with a professional interest in the subject, notably health and social care professionals, as well as students, family carers and people considering a career in these professions.
More
- News
News
Strathclyde spin-out raises £10M to develop pioneering liquid biopsy platform for early-stage cancers
DxCover, A clinical-stage diagnostics firm founded out of research carried out at the University of Strathclyde has raised almost £10 million for its novel technology for early detection of multiple cancers.
More
- News
News
Strathclyde spin-out raises £10M to develop pioneering liquid biopsy platform for early-stage cancers
DxCover, A clinical-stage diagnostics firm founded out of research carried out at the University of Strathclyde has raised almost £10 million for its novel technology for early detection of multiple cancers.
More
- News
News
Glasgow’s PneumoWave nets £7.5m for remote health sensor
Glasgow-based PneumoWave is developing a wearable device for “high-risk patient groups”. The wearable monitors the lungs to provide remote diagnostics for carers and medical services.
More
- News
News
Glasgow’s PneumoWave nets £7.5m for remote health sensor
Glasgow-based PneumoWave is developing a wearable device for “high-risk patient groups”. The wearable monitors the lungs to provide remote diagnostics for carers and medical services.
More
- News
News
£2m for Glasgow Cancer Centre to help find new treatments
Glasgow’s Experimental Cancer Medicine Centre (ECMC) and the Paediatric ECMC in the city will receive up to £2,286,575 to help develop the cancer treatments of the future.
More